Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - isoniazid, rifampicin - filmovertrukne tabletter - 150+75 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150 mg/400 mg/75 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

lupin europe gmbh - mexiletine hydrochloride - myotonic lidelser - hjertetapi - namuscla er indiceret til symptomatisk behandling af myotonia i voksne patienter med ikke-dystrofiske myotonic lidelser.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

pfizer europe ma eeig - talazoparib - bryst neoplasmer - antineoplastiske midler - talzenna er angivet som monoterapi til behandling af voksne patienter med germline brca1/2 mutationer, der har her2-negative lokalt fremskreden eller metastatisk brystkræft. patients should have been previously treated with an anthracycline and/or a taxane in the (neo)adjuvant, locally advanced or metastatic setting unless patients were not suitable for these treatments. patienter med hormon receptor (hr)-positiv brystkræft skulle have været behandlet med en forudgående endokrine-baseret terapi, eller anses uegnet til at endokrine-baseret terapi.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - rifampicin - kapsler, hårde - 150 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

astellas pharma europe b.v. - gilteritinib fumarate - leukæmi, myeloid, akut - antineoplastiske midler - xospata er angivet som monoterapi til behandling af voksne patienter med recidiverende eller refraktær akut myeloid leukæmi (aml) med en mutation flt3.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

paranova danmark a/s - ethambutolhydrochlorid, isoniazid, pyrazinamidum, rifampicin - filmovertrukne tabletter - 150+75+400+275 mg